Browsing: weightloss

The viral weight-loss drug semaglutide, which is available under the commercial names Ozempic and Wegovy, may help slow down the…

By Maggie Fick and Patrick Wingrove LONDON/NEW YORK (Reuters) – As Eli Lilly (NYSE:)’s weight-loss drug Zepbound gains ground in…

Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a…

(Reuters) – U.S. drugmaker Eli Lilly (NYSE:) expects its blockbuster weight-loss drug to officially come out of shortage in the…

The US Food and Drug Administration says some people have been hospitalized with symptoms that may be related to overdoses…

By Andrew Silver SHANGHAI (Reuters) – Novo Nordisk (NYSE:)’s hugely popular weight-loss drug Wegovy has been approved in China, it…

By Patrick Wingrove (Reuters) – Eli Lilly (NYSE:) on Friday said its popular weight-loss drug Zepbound helped resolve moderate to…

By Robin Respaut and Chad Terhune (Reuters) – For many U.S. parents seeking help for a child with obesity, the…

The market for weight-loss drugs such as Ozempic and Wegovy will keep surging due to new products including Eli Lilly’s…

By Bhanvi Satija and Patrick Wingrove(Reuters) -Explosive demand and increased manufacturing capacity for Eli Lilly (NYSE:)’s weight-loss drug Zepbound drove…